Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Bio, Digilab Join in Co-marketing, R&D Effort

NEW YORK (GenomeWeb News) – Pressure BioSciences and Digilab have struck an agreement to co-market and sell their product lines together worldwide and to pursue joint research and development projects, Digilab said today.

The companies plan to co-market their respective technologies through industry publications, at scientific meetings, through their websites, at trade shows, and through common collaborator studies.

Under the R&D collaboration, PBI and Digilab plan to co-develop new instruments, accessories for existing instruments, and consumables that combine Digilab's robotics and high-throughput capabilities with PBI's Pressure Cycling Technology platform.

According to Digilab, a combination of the companies' respective platforms will provide an improved, more reproducible, and integrated workflow for addressing a number of sample prep issues that researchers face.

"We believe that Digilab's suite of sample preparation, liquid handling, and identification products, coupled with PBI's unique pressure-based technology platform and PCT products, will offer the research scientist greatly enhanced sample preparation tools with a higher degree of reproducibility, versatility, throughput, and overall quality than currently available," Digilab Chairman and CEO Sidney Braginsky said in a statement.

PBI's President and CEO Richard Shumacher said that the collaboration with Digilab will enhance its sales, marketing, and distribution activities and that its team will help Digilab broaden its sales capabilities.